Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hepato Cellular Carcinoma × tremelimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 25 Carcinoma, Non-Small-Cell Lung 4 Liver Neoplasms 3 Biliary Tract Neoplasms 3 Pancreatic Neoplasms 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Urinary Bladder Neoplasms 1 Unresectable Hepatocellular Carcinoma 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma 1 Liver Cirrhosis 1 Hepato Cellular Carcinoma 1 Endometrial Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma 1 Adenocarcinoma Of Esophagus 1

Interventions

tremelimumab 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07489976 2026-03-27

IIT2025-03-YANG-LIFT-HCC

Cedars-Sinai Medical Center

Phase 2 Recruiting

Hepato Cellular Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡